Last Update Time:
07-Mar-2025 16:00:00
ISIN:
INE205C01021
Sector:
Healthcare
Symbol:
POLYMED
Poly Medicure Limited
₹2,278.00
₹-42.30
(-1.82%)
▼
Prev. Close
₹2,320.30
Open
₹2,338.95
Close
₹2,284.05
Range
₹2,164.10 - ₹2,391.90
High
₹2,359.80
Low
₹2,270.00
Ind. Close
₹0.00
VWAP
₹2,316.76
The current stock price of Poly Medicure Limited is ₹2,278.00, with a target price range between ₹2,164.10 and ₹2,391.90. The stock has experienced a price change of ₹-42.30 (-1.82%), reflecting recent market volatility.
Today's opening price was ₹2,338.95, while the previous close stood at ₹2,320.30.
The market trend suggests a potential downtrend, with investors exercising caution due to recent declines. Analysts recommend closely monitoring support levels.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
Poly Medicure Limited Price Chart
Poly Medicure Limited Pre Open Market Overview: 07-Mar-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 2338.95
- Previous Close Price: 2320.3
- Change: 18.65%
- Total Traded Volume: 160
- Total Buy Quantity: 1,785
- Total Sell Quantity: 2,787
| Price | Buy Qty | Sell Qty |
|---|---|---|
| 2,308.70 | 3.00 | 0.00 |
| 2,315.00 | 188.00 | 0.00 |
| 2,320.30 | 25.00 | 0.00 |
| 2,321.00 | 170.00 | 0.00 |
| 2,321.05 | 22.00 | 0.00 |
| 2,338.95 | 0.00 | 94.00 |
| 2,339.00 | 0.00 | 1.00 |
| 2,340.00 | 0.00 | 21.00 |
| 2,341.00 | 0.00 | 2.00 |
| 2,341.15 | 0.00 | 25.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
| Bid | Qty | Ask | Qty |
|---|---|---|---|
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
Total Buy Quantity: 1785
Total Sell Quantity: 2787
Shareholding Patterns of Poly Medicure Limited
Key Trade Statistics of Poly Medicure Limited
| Trade Information | Details |
|---|---|
| Traded Volume (Lakhs) | 1.00 |
| Traded Value (₹ Cr.) | 23.27 |
| Total Market Cap (₹ Cr.) | 23,082.00 |
| Free Float Market Cap (₹ Cr.) | 8,641.69 |
| Impact cost | 0.08 |
| Quantity Traded | 100,461.00 |
| Deliverable Quantity | 40,956.00 |
| % of Quantity to Traded | 40.77 |
| Security VaR | 17.57 |
| Index VaR | N/A |
| VaR Margin | 17.57 |
| Extreme Loss Rate | 3.5 |
| Adhoc Margin | N/A |
| Applicable Margin Rate | 21.07 |
| Face Value | 5 |
Key Price Statistics of Poly Medicure Limited
The 52-week high for Poly Medicure Limited was ₹3,357.80, recorded on 01-Nov-2024. On the other hand, the 52-week low stands at ₹1,373.00, with the lowest value recorded on 14-Mar-2024.
The upper band for trading is ₹2,784.35, and the lower band is ₹1,856.25. The price band is 20%.
The stock's daily volatility stands at 2.70, while the annualized volatility is 51.58. The tick size for trading is ₹0.05.
| Price Information | Details |
|---|---|
| 52 Week High (01-Nov-2024) | 3,357.80 |
| 52 Week Low (14-Mar-2024) | 1,373.00 |
| Upper Band | 2,784.35 |
| Lower Band | 1,856.25 |
| Price Band (%) | 20 |
| Daily Volatility | 2.70 |
| Annualised Volatility | 51.58 |
| Tick Size | 0.05 |
Key Securities Statistics of Poly Medicure Limited
| Securities Information | Details |
|---|---|
| Status | Listed |
| Trading Status | Active |
| Date of Listing | 07-Dec-2011 |
| Adjusted P/E | 75.37 |
| Symbol P/E | 75.37 |
| Index | NIFTY 500 |
| Macro-Economic Sector | Healthcare |
| Sector | Healthcare |
| Industry | Healthcare Equipment & Supplies |
| Basic Industry | Medical Equipment & Supplies |
Security Status of Poly Medicure Limited
| Title | Details |
|---|---|
| Board Status | Main |
| Trading Segment | Normal Market |
| Session No. | - |
| Class of Shares | Equity |
| SDD Compliance | - |
| Name of Compliance Officer | - |
Announcements of Poly Medicure Limited
| Subject | Date |
|---|---|
| Statement of deviation(s) or variation(s) under Reg. 32 | 13-Feb-2025 |
| Monitoring Agency Report | 13-Feb-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 10-Feb-2025 |
| Incorporation-XBRL | 05-Feb-2025 |
| Incorporation | 05-Feb-2025 |
| Integrated Filing- Financial | 05-Feb-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 03-Feb-2025 |
| Press Release | 03-Feb-2025 |
Corporate Actions of Poly Medicure Limited
| Face Value | Purpose | Ex-Date |
|---|---|---|
| 5 | Annual General Meeting/Dividend - Rs 3 Per Share | 19-Sep-2024 |
| 5 | Annual General Meeting/Dividend - Rs 3 Per Share | 21-Sep-2023 |
| 5 | Annual General Meeting/Dividend - Rs 2.50 Per Share | 16-Sep-2022 |
| 5 | Annual General Meeting | 16-Sep-2021 |
| 5 | Dividend - Rs 2.50 Per Share | 16-Sep-2021 |
| 5 | Annual General Meeting | 21-Sep-2020 |
| 5 | Interim Dividend - Rs 2 Per Share | 27-Feb-2020 |
| 5 | Annual General Meeting/Dividend - Rs 2 Per Share | 13-Sep-2019 |
| 5 | Annual General Meeting/Dividend- Rs 2 Per Share (Purpose Revised) | 18-Sep-2018 |
| 5 | Annual General Meeting/Dividend - Re 0.50 Per Share | 20-Sep-2017 |
| 5 | Dividend- Re 0.50 Per Share | 20-Sep-2017 |
| 5 | Bonus 1:1 | 24-Mar-2017 |
| 5 | Interim Dividend Re 1/- Per Share | 15-Feb-2017 |
| 5 | Interim Dividend Re 1/- Per Share (Purpose Revised) | 11-Nov-2016 |
| 5 | Annual General Meeting/Dividend - Re 0.50 Per Share (Purpose Revised) | 19-Sep-2016 |
| 5 | Interim Dividend - Rs 2.50/- Per Share (Purpose Revised) | 17-Mar-2016 |
| 5 | Annual General Meeting/Dividend Rs 2.50 Per Share | 18-Sep-2015 |
| 5 | Face Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 5/- Per Share | 02-Feb-2015 |
| 5 | Annual General Meeting / Dividend - Rs 4/- Per Share | 15-Sep-2014 |
| 5 | Annual General Meeting / Dividend Rs.2 Per Share | 19-Sep-2013 |
Board Meetings of Poly Medicure Limited
Financial Results of Poly Medicure Limited
Company Directory of Poly Medicure Limited
| Web Address | Office | Address | City |
|---|---|---|---|
| www.polymedicure.com | Registered Office | 232B, 3rd Floor, Okhla Industrial Estate, Phase-III, New Delhi | NEW DELHI |
| www.polymedicure.com | Transfer Agent | Mas Services Limited T 34, II Floor, Okhla Industrial Area, Phase II | NEW DELHI |
Insider Trading of Poly Medicure Limited
| Reg. Clause | Acq./Disp. | Sec. Value | Txn Type |
|---|---|---|---|
| 7(2) | RISHI BAID | 36774439 | Sell |
| 7(2) | RISHI BAID | 146185779 | Sell |
| 7(2) | RISHI BAID | 28308980 | Sell |
| 7(2) | RISHI BAID | 50860424 | Sell |
| 7(2) | RISHI BAID | 8469419 | Sell |
| 7(2) | VCB TRADING LLP | 99500000 | Sell |
| 7(2) | JAS KARAN SANCHETI OSWALj | 278520 | Sell |
| 7(2) | JAS KARAN SANCHETI OSWALj | 130054 | Buy |
| 7(2) | NIDHI OSWAL (DAUGHTER OF CFO) | 64981 | Sell |
| 7(2) | M/S. POLYCURE MARTECH LIMITED | 413400 | Buy |
| 7(2) | RISHI BAID | 36561083 | Buy |
| 7(2) | HIMANSHU BAID | 36561083 | Sell |
| 7(2) | JAS KARAN SANCHETI OSWALj | 77923 | Buy |
| 7(2) | JAS KARAN SANCHETI OSWALj | 18330 | Buy |
| 7(2) | JAS KARAN SANCHETI OSWALj | 168925 | Buy |
| 7(2) | JAS KARAN SANCHETI OSWALj | 411681 | Buy |
| 7(2) | JAS KARAN SANCHETI OSWALj | 827102 | Sell |
| 7(2) | JAS KARAN SANCHETI OSWALj | 208876 | Buy |
| 7(2) | JAS KARAN SANCHETI OSWALj | 79074 | Buy |
| 7(2) | JAS KARAN SANCHETI OSWALj | 165942 | Buy |
Annual Reports of Poly Medicure Limited
Investor Complaints of Poly Medicure Limited
Event Calendar of Poly Medicure Limited
| Purpose | Details |
|---|---|
| Board meeting Rescheduled | The Company had informed the Exchange that a meeting of the Board of Directors of the Company will be held on January 31, 2012 to consider inter -alia, Unaudited Financial Results for the quarter ended December 31, 2011. The Company has now informed the Exchange that the Company have rescheduled the aforesaid Board Meeting and the same shall be now held on January 30, 2012. |
| Results/Dividend | To consider and approve, inter alia, Audited Financial Results of the Company and to recommend payment of dividend, if any, for the Financial Year 2011-12. |
| Board meeting Rescheduled | The Company had informed the Exchange that a meeting of the Board of Directors of the Company Scheduled to be held on May 19, 2012 to consider and approve, inter alia, Audited Financial Results of the Company and to recommend payment of dividend, if any, for the Financial Year 2011-12.The Company has now informed the Exchange that the Company have rescheduled the said Board Meeting and the same shall be now held on May 28, 2012 inter-alia to consider the following business : (1) To consider and approve Audited Financial Results for the year ended on March 31, 2012. (2) To consider recommendation of dividend, if any, for the Financial Year 2011-12. |
| Results/Dividend | To consider and approve, inter alia, Annual Audited Financial Results of the Company and to recommend payment of Dividend, if any, for the Financial Year 2012-13. |
| Results | To consider & approve Un-Audited Financial Results for the quarter ended on 30th June, 2013 |
| Results | To consider and approve Inter-alia, Un-audited Financial Results of the Company for the quarter ended On September 30, 2013. |
| Results | To consider and approve, inter alia, Un-Audited Financial Results of the Company, for the quarter ended on December 31, 2013 (Q3). Further, pursuant to Code of Prevention of Insider Trading of the Company and applicable SEBI Regulations, it is informed that trading window for dealing in securities of the Company will be closed from January 15, 2014 to January 27, 2014 (both days inclusive) for all designated Employees and Directors of the Company. |
| Results/Dividend | To consider the following business:(1) The Audited Annual Financial Results of the Company for the quarter and year ended on March 31, 2014. (2) The recommendation of Final Dividend, if any, for the Financial Year 2013-14. |
| Results | To consider & approve Un-Audited Financial Results for the quarter ended on 30th June, 2014. Further, pursuant to code of prevention of Insider Trading of the Company and SEBI Regulations, it is hereby informed that the Trading Window for dealing in the Securities of the Company will be closed for the directors and designated employees with immediate effect from July 16, 2014 to July 31, 2014 (Both days inclusive). |
| Results | inter alia, to consider and approve Un-audited Financial Results of the Company for Second quarter ended on September 30, 2014. |
| Results | To consider and approve,Un-Audited Financial Results of the Company, for the Third quarter ended on December 31, 2014. |
| Results/Dividend | (1) To consider and approve Audited Financial Results (Standalone & Consolidated ) for financial year ended on March 31, 2015 (2) To consider recommendation of Dividend, if any, on the Equity Shares for the Financial Year ended on March 31, 2015. |
| Results/Others | The Company had informed the Exchange regarding the board meeting to be held on July 31, 2015 Inter alia, to consider and approve Un-Audited Financial Results for the First quarter ended on June 30, 2015. The Company has now informed the Exchange that the Board Meeting also transact any other matter which the Board may deem fit.(Purpose Revised) |
| Results | Inter alia, to consider and approve Un-Audited Financial Results for the First quarter ended on June 30, 2015. |
| Results/Others | inter alia, to consider the following : (1) To consider and approve the Un-Audited Results of the Company for the Second quarter and half year ended on September 30, 2015.(2) to transact any other matter which the Board may deem fit. |
| Results/Others | Inter alia, to consider and approve the un-audited financial results of the Company for the third quarter and nine months ended December 31, 2015 and any other matter which the Board may deem fit.. |
| Dividend | inter alia, to consider declaration of interim dividend, if any, to the shareholders of the Company, for the financial year 2015-16. |
| Results/Dividend | Inter alia1. To consider and approve the Audited Financial Results (Consolidated & Standalone) of the Company for the financial year ended on March 31, 2016.2. To consider recommendation of Dividend, if any, on the Equity Shares for the financial year ended on March 31, 2016. |
| Results/Others | inter-alia to consider the following: (1) To consider and approve the Un-Audited Financial Results of the Company for the First quarter ended on June 30, 2016. (2) To transact any other matter which the Board may deem fit. |
| Results | inter alia, to consider and approve the Un-audited Financial Results for the first quarter ended on June 30, 2016. |
| Results | Inter alia to consider and approve the Un-audited Financial Result for the second quarter and half year ended September 30, 2016. |
| Results/Dividend | inter alia to consider the following: a) To consider and approve the Un-Audited Financial Results of the Company for the Second quarter and half year ended on 30th September, 2016. b) To consider declaration of interim dividend, to the Equity Shareholders of the Company for the current financial year 2016-17. |
| Results/Dividend/Bonus | Inter alia to consider the following: a) To consider and approve the Un-Audited Financial Results of the Company for the Third quarter and Nine months ended on December 31, 2016. b) To consider declaration of 2nd interim dividend, to the Equity Shareholders of the Company for the current financial year 2016-17. c) To consider the issue of Bonus Shares, subject to approval of shareholders to be obtained in this behalf. d) To transact any other matter which the Board may deem fit. |
| Results/Dividend | inter alia to consider the following: a) To consider and approve the Audited Financial Results (Consolidated & Standalone) of the Company for the financial year ended on March 31, 2017. b) To consider recommendation of Dividend, if any, on the Equity Shares for the financial year ended on March 31, 2017. c) To transact any other matter which the Board may deem fit. |
| Results | inter alia, to consider and approve the Audited Financial Results for the year ended on March 31, 2017. |
| Results/Others | Inter-alia to consider the following: To consider and approve the Un-Audited Financial Results of the Company for the First quarter ended on June 30, 2017. To transact any other matter which the Board may deem fit. |
| Results | Inter alia, to consider and approve the Un-audited Financial Results for the second quarter and half year ended on September 30, 2017. |
| Results/Others | Inter alia to consider the following: a) To consider and approve the Un-Audited Financial Results of the Company for the Third quarter and Nine months ended on December 31, 2017. b) To transact any other matter which the Board may deem fit. |
| Results | inter alia, to consider and approve the Un-audited Financial Results for the third quarter and nine months ended on December 31, 2017. |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2018 |
| Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended March 31, 2018, dividend and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2018 and other business matters |
| Financial Results | Inter alia, to consider and approve the Un-audited Financial Results for the first quarter ended on Jun 30, 2018. |
| Financial Results | Inter alia, to consider and approve the Un-audited Financial results for the second quarter and half year ended on September 30, 2018. |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2018 |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2018 and other business matters |
| Financial Results | Inter alia, to consider and approve the Un-audited Financial Results for the third quarter and nine Months ended on December 31, 2018. |
| Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended March 31, 2019, dividend and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2019 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2019 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2019 and other business matters |
| Dividend/Other business matters | To consider dividend and other business matters |
| Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended March 31, 2020, dividend and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2020 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2020 and other business matters |
| Fund Raising/Other business matters | To consider Fund Raising and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2020 and other business matters |
| Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended March 31, 2021, dividend and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2021 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2021 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2021 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2022 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2023 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2023 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2023 and other business matters |
| Fund Raising/Other business matters | To consider Fund Raising and other business matters |
| Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended March 31, 2024, dividend and other business matters |
| Fund Raising/Other business matters | To consider Fund Raising and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2024 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2024 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2024 and other business matters |
Share Transfers of Poly Medicure Limited
Voting Results of Poly Medicure Limited
| Date of Mtg. | Mtg. Type | Resolution |
|---|---|---|
| 23-JAN-2025 | Postal Ballot | TO CONSIDER AND APPROVE THE APPOINTMENT OF MR. VISHAL GUPTA (DIN: 00097939) AS AN nINDEPENDENT DIRECTOR OF THE COMPANY |
| 23-JAN-2025 | Postal Ballot | TO CONSIDER AND APPROVE THE APPOINTMENT OF MR. VISHAL GUPTA (DIN: 00097939) AS AN |
| 26-SEP-2024 | AGM | To receive, consider and adopt n￢ﾀﾢ the Audited Standalone Financial Statement for the Financial Year ended 31st March, 2024 together with the reports of the Board of Directors and Auditors thereon; and n￢ﾀﾢ the Audited Consolidated Financial Statements for the Financial Year ended 31st March, 2024 together with the report of Auditors thereon. |
| 26-SEP-2024 | AGM | To Ratification of Remuneration to M/s. Jai Prakash & Company, Cost Accountants appointed as Cost Auditors of the Company for the Financial Year 2024-25. |
| 26-SEP-2024 | AGM | To approve payment of remuneration to Non-Executive Directors. |
| 26-SEP-2024 | AGM | To appoint Shri Aaryaman Baid as Senior Manager, Corporate Strategy. |
| 26-SEP-2024 | AGM | To appoint Shri Arham Baid as Senior Manager, Corporate Strategy. |
| 26-SEP-2024 | AGM | To approve adoption of amended and restated Articles of Association of the Company. |
| 26-SEP-2024 | AGM | To approve Mrs. Mukulika Baid to continue to hold office as Non-Executive Non-Independent Director who is attaining age of 75 (seventy-five) Years. n |
| 26-SEP-2024 | AGM | To appoint Mr. Vimal Bhandari as Non-Executive and Independent Director. |
| 26-SEP-2024 | AGM | To re-appoint Shri Rishi Baid as the Joint Managing Director. |
| 26-SEP-2024 | AGM | To re-appoint Shri Himanshu Baid as the Managing Director |
| 26-SEP-2024 | AGM | To re-appoint Mr. Devendra Raj Mehta as Non-Executive Non- Independent Director. |
| 26-SEP-2024 | AGM | To appoint Auditor and to fix their remuneration. |
| 26-SEP-2024 | AGM | To appoint a director in place of Mr. Alessandro Balboni who retires by rotation and being eligible, offer himself for re-appointment. |
| 26-SEP-2024 | AGM | To declare dividend on Equity Shares for financial year 2023-24. |
| 05-AUG-2024 | Postal Ballot | Approval For raising of Funds by issuance of equity shares through Qualified Institutions Placement(s). |
| 05-AUG-2024 | Postal Ballot | Appointment of Shri Dhruv Baid as Senior Manager, International Business Development. |
| 28-SEP-2023 | AGM | To receive, consider and adopt the Audited Standalone Financial Statement for the Financial Year ended 31st MARCH, 2023 together with the reports of the Board of Directors and Auditors thereon; and the Audited Consolidated Financial Statements for the Financial year ended 31st March, 2023 together with the report of Auditors thereon. |
| 28-SEP-2023 | AGM | To declare Dividend on Equity Shares for the Financial Year 2022-23. |
FAQs on Poly Medicure Limited
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.